A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the ...

Merck will buy Minneapolis-based Bio-Techne Corp. in a deal worth $11.3 billion. Bio-Techne was under pressure from an ...

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the ...

The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.

In the past year, Merck KGaA has turned its attention to growing its business in supplies for the life sciences industry. The ...

May 1(Reuters) - Bio-Techne (TECH.O), opens new tab on Wednesday beat third-quarter profit and revenue estimates, helped by better-than-expected demand for its cell and gene therapy products and ...

Germany's Merck boosts life sciences business with $11 billion bet on Bio-Techne German drugmaker Merck KGaA said on Thursday ‌it would buy U.S. firm Bio-Techne for $11.3 billion, its biggest deal in ...

Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.

While Bio-Techne stock has underperformed the broader market over the past year, analysts remain moderately bullish about its ...

Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.